Welkin Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 15-12-2024
- Paid Up Capital ₹ 0.10 M
as on 15-12-2024
- Company Age 10 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.64 M
as on 15-12-2024
- Revenue -20.07%
(FY 2021)
- Profit 39.09%
(FY 2021)
- Ebitda 21.95%
(FY 2021)
- Net Worth 443.80%
(FY 2021)
- Total Assets 2.14%
(FY 2021)
About Welkin Healthcare
The Company is engaged in the Automotive Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.64 M.
Akash Bansal and Zubin Bansal serve as directors at the Company.
- CIN/LLPIN
U15500HP2014PTC000687
- Company No.
000687
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Mar 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Company Details
- Location
Solan, Himachal Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Welkin Healthcare Private Limited offer?
Welkin Healthcare Private Limited offers a wide range of products and services, including E Vehicles, Electric Three Wheeler, Parts and Kits, Farming and Pet Animals, Farm Animals.
Who are the key members and board of directors at Welkin Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Akash Bansal  | Director | 21-Mar-2014 | Current |
| Zubin Bansal | Director | 21-Mar-2014 | Current |
Financial Performance of Welkin Healthcare.
Welkin Healthcare Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 20.07% decrease. The company also saw a substantial improvement in profitability, with a 39.09% increase in profit. The company's net worth Soared by an impressive increase of 443.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Welkin Healthcare?
In 2021, Welkin Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Welkin Ecoventures Private LimitedActive 5 years 11 monthsAkash Bansal and Zubin Bansal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 25 Apr 2024 | ₹1.64 M | Open |
How Many Employees Work at Welkin Healthcare?
Unlock and access historical data on people associated with Welkin Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Welkin Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Welkin Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
